Most Recent
Pharmacor has accused AstraZeneca of launching a royal commission into emails with its lawyers as AstraZeneca opposes the generic drug maker's bid to amend its pleading in a patent case over diabetes drug Forxiga.
ASIC has opened an insider trading investigation into the trading of retailer Accent Group's shares, asking the company to preserve communications by its CEO Daniel Agostinelli.
Insurer Allianz Australia has been unsuccessful in an application to limit Uniting Church's coverage for historical sexual misconduct claims to $15 million under a professional indemnity policy.
Liquidators for billionaire Sanjeev Gupta’s Tahmoor Coal are planning to bring a case against secured creditor Clydesdale Engineering, challenging its entitlement to be paid out during the liquidation.
Deakin University has won an injunction barring a former professor from running his research business as 'Blue Carbon Lab', finding the university owns the associated trade marks.
Two former directors of food supplier PMFresh can't withdraw admissions in a case alleging they used company funds for personal benefit, despite a related police investigation.
Film producer Greer Simpkin thought ‘The Deb’ actress Charlotte MacInnes was “fudging” when she walked back an alleged complaint to director Rebel Wilson, a court has heard.
Lender White Oak may argue that settlement communications in proceedings over the collapse of supply chain finance company Greensill were in furtherance of fraud and should be turned over, after partially succeeding in a privilege fight with insurers BCC Trade Credit and Tokio Marine.
Another former director of collapsed Melbourne over-the-counter derivatives broker Berndale Capital Securities has pleaded guilty to misusing company funds, after his fellow director was sentenced to prison time.
A judge has again voiced doubts about the ACCC's misleading conduct case over Woolworths' 'Prices Dropped' campaign, probing counsel for the regulator at length on Thursday about how the claims stack up.